• English
  • Español
  • CONTACT US
  • HOME
ONCOMATRYX

ONCOMATRYX

pioneering stromal medicine

Menu

  • ABOUT
    • TARGETING TUMOR STROMA
    • LEADERSHIP
    • SCIENTIFIC ADVISORY BOARD
    • COLLABORATIONS
    • PUBLICATIONS
  • DRUG DISCOVERY
    • PRECISION DRUGS
    • ANTIBODY DRUG CONJUGATES
      • ADC OMTX705
      • ADC OMTX703
    • PIPELINE
  • DIAGNOSTICS
    • COL11A1 BIOMARKER
    • INVASIVE TUMOR DIAGNOSTICS -invaScan-
    • BLADDER CANCER DIAGNOSTICS -bladderScan-
  • COMPANION DX
    • COMPANION DIAGNOSTICS
  • BLOG
    • TEAM POSTS
    • NEWS
    • PRESS Releases
    • VIDEO
  • CONTACT
    • CONTACT US
    • CAREERS
    • NEXT EVENT

stroma

War on cancer stroma: a novel pathway to treat pancreatic cancer

War on cancer stroma: a novel pathway to treat pancreatic cancer

War on cancer stroma: a novel pathway to treat pancreatic cancer By Laureano Simon, CEO at Oncomatryx Pancreatic cancer is the fourth most fatal cancer in men and women. Most patients

Oncomatryx2015-12-042016-11-15 TEAM POSTS No Comments Read more

Archives

  • March 2022
  • November 2020
  • October 2018
  • February 2018
  • April 2017
  • February 2017
  • November 2016
  • September 2016
  • August 2016
  • April 2016
  • February 2016
  • December 2015
  • July 2015
  • May 2015
  • June 2013
  • January 2013

Meta

  • Log in

PRECISION DRUGS

  • PRECISION DRUGS
  • ANTIBODY DRUG CONJUGATES
  • PIPELINE

DIAGNOSTICS

  • COL11A1 BIOMARKER
  • INVASIVE TUMOR DIAGNOSTICS -invaScan-
  • BLADDER CANCER DIAGNOSTICS -bladderScan-

With the collaboration of:

ONCOMATRYX BIOPHARMA SL ©2019
  • English
  • Español
  • TERMS OF USE
  • PRIVACY POLICY
  • SITE MAP